10 Best IPO Stocks To Buy Heading into 2025
The current climate in the IPO market suggests a potential rebound, particularly looking ahead to 2025.
Cg Oncology Inc. (CGON)
Market is closed
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $19.00 | 400,000 | 4,958,810 | 2024-01-29 | Filing | ||
| $19.00 | 1,315 | 1,315 | 2024-01-29 | Filing | ||
| $19.00 | 2,000 | 2,000 | 2024-01-29 | Filing | ||
| $19.00 | 263,157 | 613,928 | 2024-01-29 | Filing | ||
| $19.00 | 400,000 | 400,000 | 2024-01-29 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $35.36 | 226,245 | 3,703,931 | 2024-08-29 | Filing | ||
| $35.36 | 424,210 | 586,982 | 2024-08-29 | Filing |
News See All
10 Worst Cancer Stocks To Buy Now According to Short Sellers
Cancer is the second leading cause of death globally, just behind cardiovascular disease, making oncology one of the largest sectors in the life sciences.
Billionaire Hedge Funds
